Assessment of Skeleton Health - PowerPoint PPT Presentation

About This Presentation
Title:

Assessment of Skeleton Health

Description:

Osteoporosis Normal Osteopenia Osteoporosis Osteoporosis Normal bone Osteoporosis is defined as a skeletal disorder characterized by: ... – PowerPoint PPT presentation

Number of Views:1150
Avg rating:3.0/5.0
Slides: 63
Provided by: vietscien
Category:

less

Transcript and Presenter's Notes

Title: Assessment of Skeleton Health


1
Assessment of Skeleton Health
  • Tuan Van Nguyen and Nguyen Dinh Nguyen
  • Garvan Institute of Medical Research
  • Sydney, Australia

2
Overview
  • Background
  • Normal bone and bone remodelling
  • Bone loss and age
  • Definitions
  • Measurements of bone strength
  • Bone mass and DXA, QUS
  • Bone turnover markers

3
Background
  • Aging population fastest growing age group
  • Osteoporosis and osteoporotic fracture
    age-related disorders
  • Osteoporosis and osteoporotic fracture
  • Common
  • Cause serious disability and excess mortality
  • Major economic burden on healthcare system

4
Residual lifetime risk of different diseases
Women
Men
(Source Nguyen ND et al, 2006, under review
process)
5
Survival probability and fracture
Women
Men
Cumulative survival rate
Age (y)
(Soure Center J, Nguyen TV et al., Lancet
1999353878-82)
6
Burden of Osteoporotic fractures
  • Annual cost of all osteoporotic fractures 20
    billion in USA and 30 billion on EU1.
  • Worldwide direct and indirect cost of hip
    fracture US131.5 billion2.

(Sources 1Cummings et al., Lancet
20023591761-67 2Johnell O, Am J Med
199710320S-26)
7
Cortical and Trabecular Bone
Cortical Bone
  • 80 of all the bone in the body
  • 20 of bone turnover

Trabecular Bone
  • 20 of all bone in the body
  • 80 of bone turnover

8
Cortical (Compact) Bone
  • 80 of the skeletal mass
  • Provides a protective outer shell around every
    bone in the body
  • Slower turnover
  • Provides strength and resists bending or torsion

9
Trabecular (Cancellous) Bone
  • 20 of the skeletal mass, but 80 of the bone
    surface.
  • less dense, more elastic, and higher turnover
    rate than cortical bone.
  • appears spongy
  • found in the epipheseal and metaphysal regions of
    long bones and throughout the interior of short
    bones.
  • constitutes most of the bone tissue of the axial
    skeleton (skull, ribs and spine).
  • interior scaffolding maintains bone shape despite
    compressive forces.

10
Distribution of Cortical and Trabecular Bone
Thoracic and 75 trabecular Lumbar Spine 25
cortical
1/3 Radius gt95 Cortical
Femoral Neck 25 trabecular 75 cortical
Ultradistal Radius 25 trabecular 75 cortical
Hip Intertrochanteric Region 50 trabecular 50
cortical
11
How does bone loss happen?
  • Bone is a living, growing, tissue
  • Healthy bones are not quiescent. They are
    constantly being remodeled.
  • This is not simply a problem of bony destruction,
    but imbalance between the formation and
    destruction of bone.

12
Bone remodeling cycle
13
Bone remodeling cycle
Pre-osteoblasts
Monocytes
Osteoblasts
Osteoclasts
Osteocytes
14
Bone loss
Bone formation
Bone resorption
Bone formation
Bone resorption
15
Bone mass declines with age
  • Remodeling occurs at discrete foci called bone
    remodeling units (BRUs).
  • Number of active BRUs ? with age ? ? bone
    turnover.
  • Osteoblasts not able to completely fill cavities
    created by osteoclasts and less mineralized bone
    is formed.
  • Endosteal bone loss partially compensated by
    periosteal bone formation ? trabecular thinning.

16
Relative Influence of Inner and Outer Diameters
on Bone Strength
(Adapted from Lee CA, and Einhorn TA.
Osteoporosis 2nd Ed. 2001)
17
Gain and loss of Bone throughout the lifespan
Pubertal Growth Spurt
Menopause
BMD
Resorption
Formation
Age (Years)
18
Relationship between BMD and Age
(VN 2006, unpublished data)
19
Definition of Osteoporosis(WHO)
  • A systematic skeleton disease characterized by
  • low bone mass
  • microarchitectural deterioration of bone tissue
  • consequent increase in bone fragility and
    susceptibility to fracture

Consensus Development Conference Diagnosis,
Prophylaxis, and Treatment of Osteoporosis, Am J
Med 199394646-650. WHO Study Group 1994.
20
Osteoporosis
21
Osteoporosis
Normal bone
22
Definition of Osteoporosis(NIH)
  • Osteoporosis is defined as a skeletal disorder
    characterized by
  • compromised bone strength predisposing a person
    to an increased risk of fracture.
  • bone strength primarily reflects the integration
    of bone density and bone quality.

(Source NIH Consensus Development Panel on
Osteoporosis JAMA 285785-95 2001)
23
BONE STRENGTH
BONE MINERAL DENSITY
BONE QUALITY
Bone architecture
Gram of mineral per area
Bone turnover
Bone size geometry
24
Bone Quality
  • Architecture
  • Turnover Rate
  • Damage Accumulation
  • Degree of Mineralization
  • Properties of the collagen/mineral matrix

( NIH Consensus Development Panel on
Osteoporosis. JAMA 285785-95 2001)
25
Bone mass, Bone mineral density (BMD)
  • Bone mass the amount of bone tissue as the
    total of protein and mineral or the amount of
    mineral in the whole skeleton or in a particular
    segment of bone. (unmeasurable)
  • BMD the average concentration of mineral per
    unit area ? assessed in 2 dimensions (measurable)

26
Effect of Size on Areal BMD
BMC
AREA
BMD
1
1
1
1
1
1
2
2
8
4
2
2
3
3
27
9
3
3
TRUE VALUE 1 g/cm3
(Adapted from Carter DR, et al. J Bone Miner Res
1992)
27
Bone Densitometry
  • Non-invasive test for measurement of BMD
  • Major technologies
  • Dual-energy X-ray Absorptiometry (DXA)
  • Quantitative Ultrasound (QUS)
  • Quantitative Computerized Tomography (QCT)
  • Many manufacturers
  • Numerous devices
  • Different skeletal sites

28
DXA (or DEXA)
29
DXA (or DEXA)
  • Gold-standard for BMD measurement
  • Measures central or axial skeletal sites
    spine and hip
  • May measure other sites total body and forearm
  • Extensive epidemiologic data
  • Correlation with bone strength in-vitro
  • Validated in many clinical trials

30
DXA Technology
Detector (detects 2 tissue types - bone and soft
tissue)
Very low radiation to patient. Very little
scatter radiation to technologist
Patient
Collimator (pinhole
for pencil beam, slit for fan beam)
Photons
X-ray Source
(produces 2 photon energies with
different attenuation profiles)
31
DXA BMD scan
Spine
Hip
Total body
32
DXA Femoral neck BMD
33
DXA Lumbar spine BMD
34
DXA Hip BMD Results
35
Which Skeletal Sites Should Be Measured?
  • Every Patient
  • Spine
  • L1-L4 (L2-L4)
  • Hip
  • Total Proximal Femur
  • Femoral Neck
  • Trochanter
  • Some Patients
  • Forearm (33 Radius)
  • If hip or spine cannot be measured
  • Hyperparathyroidism
  • Very obese

36
BMD measurement subject to variability
  • In vivo/in situ BMD inaccuracy effect of bone
    structure, bone size and shape, and extra-osseous
    soft tissue
  • Measurement error within subject and
    between-subject variations.
  • Between machine variation.

37
In vivo/In situ BMD inaccuracy
REGION OF INTEREST
Lateral region
Lateral region
Bone region
Trabeculaae Marrow
Extra-Osseous FatLean tissue
Cortical region
(Adapted from Bolotin HH, Med Phys 200431774-88)
X-RAY PATHS
38
In vivo/In situ BMD inaccuracy
Under-/or over-estimate BMD () Under-/or over-estimate BMD () Under-/or over-estimate BMD ()
Normal Osteopenia Osteoporosis
Typical lumbar vertebral bone site 25 35 Up to 50
Distal radius, femur 20 25 35
Trabecular-free sites (mid-shaft femur, mid-shaft radius) lt2
Individual
Type of bone
(Source Bolotin HH, Med Phys 200431774-88)
39
Source of variability in BMD measurements
Number of measurements per subject required to
increase the reliability of measurement for a
given coefficient of reliability
(Source Nguyen TV et al., JBMR 199712124-34)
40
Standard error of rate of change in BMD
Individual
Group
(Source Nguyen TV et al., JBMR 199712124-34)
41
Source of variability in BMD measurements
  • Group level Intra-subject estimation error could
    contribute about 90 of the variability component
    ? ? power of study, and underestimate the RR
    (BMD-fracture).
  • Individual level? false ve false ve error
    rates of diagnostic BMD.
  • ? measurement error by multiple measurement.
  • ? long-term intra-subject variation by ? the
    length of follow-up and/or ? the frequency of
    measurements.
  • Studies with 3-5 yrs of follow-up optimal cost
    benefits.
  • More than 2 measurements/year not improve the
    precision appreciably.

(Source Nguyen TV et al., JBMR 199712124-34)
42
True level and True biological change of BMD
  • Factors affect to BMD level and BMD change
  • Invivo/in situ BMD inaccuracy
  • Random error
  • Measurement errors intra- and between-subject
    variability
  • Systematic errors
  • Effect of regression-toward-the mean

(Sources Bolotin HH, Med Phys 200431774-88
Nguyen TV et al., JBMR 199712124-34 Nguyen TV
et al, JCD 20003107-19)
43
True level and True biological change of BMD
  • BMD level
  • Good agreement between observed and true values
  • Individual with low BMD 20 false ve and false
    ve of diagnosis of osteoporosis.
  • BMD change
  • Overall average increase in BMD of 2 no
    conclusion of significant change for an
    individual.
  • An observed ? of at least 5.5 or ? of at least
    7.5 could be a significantly biological change.

(Source Nguyen TV et al, JCD 20003107-19)
44
BMD Values From Different Manufacturers Are Not
Comparable
  • Different dual energy methods
  • Different calibration
  • Different detectors
  • Different edge detection software
  • Different regions of interest

45
Peripheral BMD TestingAccurate Precise
  • What it can do
  • Predict fracture risk
  • Tool for osteoporosis education
  • What it cannot do
  • Diagnose osteoporosis
  • Monitor therapy
  1. A normal peripheral test does not necessarily
    mean that the patient does not have osteoporosis.
  2. WHO criteria do not apply to peripheral BMD
    testing.

46
Quantitative Ultrasound (QUS)
  • Broad-band ultrasound attenuation or ultrasound
    velocity
  • No radiation exposure
  • Cannot be used for diagnosis
  • Preferred use in assessment of fracture risk

47
Bone Quality
Architecture Turnover Rate Damage
Accumulation Degree of Mineralization Properties
of the collagen/mineral matrix
( NIH Consensus Development Panel on
Osteoporosis. JAMA 285785-95 2001)
48
Cortical and Trabecular Bone
Cortical Bone
  • 80 of all the bone in the body
  • 20 of bone turnover

Trabecular Bone
  • 20 of all bone in the body
  • 80 of bone turnover

49
Relevance of Architecture
Normal Loss of Loss of Quantity Quantity
and Quantity and Architecture Architecture
50
Bone ArchitectureTrabecular Perforation
The effects of bone turnover on the structural
role of trabeculae
Risk of Trabecular Perforation increases with
  • Increased bone turnover
  • Increased erosion depth
  • Predisposition to trabecular thinning

51
Structural Role of TrabeculaeCompressive
strength of connected and disconnected trabeculae
1
16 X
Bell et al. Calcified Tissue Research 1 75-86,
1967
52
Resorption Cavities as Mechanical Stress Risers
(Adapted from Parfitt A.M. et al. Am J Med 91,
Suppl 5B 5B-34S)
53
Hip strength indice
  • CSMI (cm4) Cross-sectional moment of inertia
  • CSA (cm2) Cross sectional area
  • Z (cm3) Section modulus CSMI/distance from the
    centre of the mass to the superior neck margin.
  • Cstress (N/mm2) Compressive stress on the
    superior surface of the FN during a fall on the
    greater trochanter. Calculated by combining CSMI
    and CSA.
  • FND (cm) Femoral neck Diameter
  • Buckling ratio radius/thickness

54
Cross-Sectional Moment of Inertia CSMI ?/4
(r4 outer r4 inner)
Area (cm2) 2.77 2.77 2.77 CSMI (cm4) 0.61 1.06 1.5
4 Bending Strength 100 149 193
55
Bone strengh indice summary
  • Not well-studied
  • Derived from BMC, BMD, and several assumptions
  • Used in research field.

56
Bone Turnover Markers
  • Components of bone matrix or enzymes that are
    released from cells or matrix during the process
    of bone remodeling (resorption and formation).
  • Reflect but do not regulate bone remodeling
    dynamics.

57
Urinary Markers of Bone Resorption
  • Marker Abbreviation
  • Hydroxyproline HYP
  • Pyridinoline PYD
  • Deoxypyridinoline DPD
  • N-terminal cross-linking telopeptide of type I
    collagen NTX
  • C-terminal cross-linking telopeptide of type I
    collagen CTX

(Source Delmas PD. J Bone Miner Res 162370
2001)
58
Serum Markers of Bone Turnover
  • Marker Abbreviation
  • Formation
  • Bone alkaline phosphatase ALP (BSAP)
  • Osteocalcin OC
  • Procollagen type I C-propeptide PICP
  • Procollagen type I N-propeptide PINP
  • Resorption
  • N-terminal cross-linking telopeptide of
    type I collagen NTX
  • C-terminal cross-linking telopeptide of
    type I collagen CTX
  • Tartrate-resistant acid phosphatase TRAP

(Source Delmas PD. J Bone Miner Res 162370,
2001)
59
Bone Turnover Effects Bone Quality
  • Very low turnover ?excessive mineralization and
    the accumulation of microdamage
  • Very high turnover ? accumulation of perforations
    and a negative bone balance

60
Summary
  • Osteoporosis and osteoporotic fractures are
    common among aging population
  • Gold standard of assessment skeleton health is
    BMD via DXA machine.
  • BMD measurement is subject to bias and errors.
  • Additional measure of bone health QUS (BMD),
    bone strength indice and bone turnover markers.

61
L?i C?m t?
  • Chúng tôi xin chân thành cám on Công ty Du?c ph?m
    Bridge Healthcare, Australia là nhà tài tr? cho
    h?i th?o.

62
Thank you!
Write a Comment
User Comments (0)
About PowerShow.com